Being at the right place at the right time is a well-established principle of success for people that also applies to ion channels. Proper localization is especially important for vertebrate Na~v~ channels, which must be clustered at high density to generate and/or propagate action potentials. In cardiomyocytes, Na~v~ channels (principally Na~v~1.5) are clustered at intercalated discs, where, together with gap junctions, they transmit action potentials between cells, and are also clustered at T tubules, where they activate voltage-sensitive calcium channels ([Fig. 1](#fig1){ref-type="fig"}; [@bib2]; [@bib14]). Several findings have implicated the ankyrin family of membrane adaptors in Na~v~ channel clustering and localization in excitable membranes of both neurons and the heart. Vertebrate Na~v~ channels share a conserved ankyrin-binding motif ([@bib3]; [@bib7]). Moreover, Na~v~ β subunits also exhibit ankyrin-binding activity ([@bib9]). Knockout of ankyrin-G in the postnatal mouse cerebellum results in the loss of Na~v~1.6 from Purkinje neuron axon initial segments ([@bib15]; [@bib4]). Na~v~1.5 in the heart colocalizes and coimmunoprecipitates with ankyrin-G ([@bib10]). Furthermore, E1053K mutation in the ankyrin-binding motif of the cardiac Na~v~1.5 channel abolishes ankyrin binding and causes Brugada Syndrome, a cardiac arrhythmia caused by the loss of function of Na~v~1.5 ([@bib10]). The same E1053K mutation also prevents delivery of Na~v~1.5 to the cardiomyocyte plasma membrane ([@bib10]).

Figure 1.**Schematic model depicting the association of Na~v~ channels with ankyrin-G/spectrin at intercalated discs and T tubules in cardiomyocytes.** Evidence for this scheme is that Na~v~1.5, the predominant Na~v~ channel in the heart, binds to ankyrin-G, requires ankyrin-G for cell surface expression, and, at steady state, colocalizes with ankyrin-G.

Although consistent with a requirement for a direct interaction with ankyrin-G for Na~v~ channel localization in neurons and cardiomyocytes, other interpretations of these experiments are also possible. For example, knockdown of ankyrin-G in the cerebellum also affected the localization of neurofascin ([@bib15]; [@bib4]), which potentially could stabilize Na~v~1.6 through interaction with sodium channel β subunits ([@bib13]). Similarly, the Brugada mutation of Na~v~1.5 could perturb an interaction with other ankyrins or unrelated proteins.

Lowe et al. (see p. 173 of this issue) address these issues in the heart with the demonstration that siRNA-mediated knockdown of ankyrin-G but not ankyrin-B abolishes the surface expression of Na~v~1.5 in neonatal as well as adult cardiomyocytes. The study further demonstrates that loss of cell surface Na~v~1.5 in ankyrin-G--depleted neonatal cardiomyocytes can be reversed by rescue with a version of ankyrin-G that is resistant to siRNA. Moreover, mutation of ankyrin-G that abolishes the binding activity for Na~v~1.5 also abolishes the ability to restore cell surface Na~v~1.5. [@bib8] also take the localization of ankyrin-G and Na~v~1.5 to the ultrastructural level with the demonstration by immunogold labeling of coclusters of Na~v~1.5 and ankyrin-G in adult cardiomyocyte membranes. These data, together with previous observations ([@bib10]), satisfy the equivalent of Koch\'s postulates for physiological interactions between proteins: (1) Na~v~1.5 and ankyrin-G colocalize at high resolution in cardiomyocytes and coimmunoprecipitate from heart tissue; (2) Na~v~1.5 localization in cardiomyocytes is lost with (a) a point mutation of Na~v~1.5 that abolishes binding to ankyrin-G, (b) depletion of ankyrin-G, and (c) mutation of ankyrin-G that abolishes binding to Na~v~1.5; and (3) mutation of Na~v~1.5 in an organism (in this case humans) causing the loss of ankyrin binding results in a phenotype that is consistent with the loss of Na~v~1.5 function (i.e., Brugada Syndrome).

These findings raise the question of whether the ankyrin-G pathway is used by other components of intercalated discs and T tubules. In axon initial segments, ankyrin-G is required for the localization of KCNQ2/3 channels and neurofascin in addition to Na~v~1.6 ([@bib4]; [@bib1]; [@bib11]; [@bib12]). Interestingly, each of these proteins has independently evolved an ankyrin-binding motif ([@bib11]). It is possible that multiple, unrelated proteins in the heart also could engage the ankyrin-G machinery for coordinated localization in the same specialized domain. Given that T tubules and intercalated discs both contain ankyrin-G yet have distinct proteins, additional mechanisms must exist for fine-tuning the composition of these domains.

What is the role of ankyrin-G in the delivery and/or retention of Na~v~1.5 to the cell surface? One possibility is that ankyrin-G and spectrin act as a scaffold that retains Na~v~1.5 after delivery and prevents endocytosis. However, studies of ankyrin-G in epithelial cells suggest a more complex mechanism ([@bib5],[@bib6]). Ankyrin-G in these cells collaborates with β2 spectrin in formation of the lateral membrane and in exit of epithelial cadherin from the trans-Golgi network ([@bib5],[@bib6]). It will be important to evaluate the role of ankyrin-G in the assembly of intercalated discs and Na~v~1.5-enriched domains of T tubules in cardiomyocytes. A current technical challenge is that these cell surface domains are not fully differentiated in neonatal cardiomyocytes, whereas adult cardiomyocytes frequently lose their morphology and viability after several days in culture. Ultimately, it will be of great interest to resolve the cell biology underlying the targeting of Na~v~1.5 as well as other membrane-spanning proteins, such as gap junction subunits and calcium channels, whose localization in differentiated cardiomyocytes is key to their physiological function.
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